TREATMENT OF METASTATIC COLORECTAL-CARCINOMA WITH CISPLATIN AND 5-FU

被引：0
|
作者：
SHEPARD, KV
FAINTUCH, J
BITRAN, JD
SWEET, DL
ROBIN, E
LEVIN, B
机构：
[1] UNIV CHICAGO HOSP & CLIN,DEPT MED,GASTROINTESTINAL ONCOL UNIT,5841 S MARYLAND AVE,BOX 400,CHICAGO,IL 60637
[2] MICHAEL REESE HOSP & MED CTR,DEPT MED,CHICAGO,IL 60616
[3] HINDALE HOSP,DEPT MED,CHICAGO,IL
[4] INGALLS HOSP,DEPT MED,CHICAGO,IL
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [21] Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma
    Lee, Ji Eun
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    You, Young Kyoung
    Lee, Myung Ah
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) : 235 - 241
  • [22] CISPLATIN PLUS 5-FU FOR THE TREATMENT OF ADENOCARCINOMA OF THE COLON
    LOEHRER, PJ
    EINHORN, LH
    WILLIAMS, SD
    HUI, SL
    ESTES, NC
    PENNINGTON, K
    CANCER TREATMENT REPORTS, 1985, 69 (12): : 1359 - 1363
  • [23] PHASE II STUDY OF HEPATIC-ARTERY INFUSION (HAI) WITH 5-FU AND MITOMYCIN-C (MITO C) IN METASTATIC COLORECTAL-CARCINOMA
    THEODORS, A
    BUKOWSKI, RM
    HEWLETT, JS
    WEICK, J
    GROPPE, C
    LIVINGSTON, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 162 - 162
  • [24] Building on the foundation of 5-FU to treat metastatic colorectal cancer
    Eng, Cathy
    ONCOLOGY-NEW YORK, 2008, 22 (04): : 462 - +
  • [25] RANDOMIZED PHASE-II STUDY OF A COMBINATION OF CISPLATIN (DDP), 5-FLUOROURACIL (5-FU), AND ALLOPURINOL (HPP) VERSUS 5-FU IN ADVANCED COLORECTAL-CARCINOMA - AN EORTC GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP-STUDY
    BLEIBERG, H
    VANDERLINDEN, B
    BUYSE, M
    HAEGELE, P
    PAILLOT, B
    TAGNON, A
    WILS, J
    CARTEI, G
    FORNASIERO, A
    DUEZ, N
    CANCER INVESTIGATION, 1990, 8 (05) : 471 - 475
  • [26] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [27] PHASE-I STUDY OF MECCNU GIVEN IN COMBINATION WITH 5-FU PLUS HIGH-DOSE FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
    WEEKS, A
    ABBRUZZESE, J
    RABER, M
    GRAVEL, D
    AJANI, J
    LEVIN, B
    GREM, J
    CHUN, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 203 - 203
  • [28] TREATMENT OF ADVANCED COLORECTAL-CARCINOMA WITH HIGH-DOSE METHOTREXATE (HD-MTX) GIVEN ALONE AND IN COMBINATION WITH 5-FLUOROURACIL (5-FU)
    ISACOFF, WH
    TISMAN, G
    BLOCK, JB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 381 - 381
  • [29] Comparative cardiac toxicity in two treatment schedules of 5-FU/LV for colorectal carcinoma
    Najam, Rahila
    Bano, Nusrat
    Mateen, Ahmed
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 26 (05) : 1013 - 1022
  • [30] ADDITIVE HYALURONIDASE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
    POSSINGER, K
    WAGNER, H
    MULLER, A
    SCHALHORN, A
    WILMANNS, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1988, 100 (24) : 13 - 14
12345